Total Payments
$54,299
2024 Payments
$1,058
Companies
29
Transactions
748
Medicare Patients
628
Medicare Billing
$84,298
Payment Breakdown by Category
Other$41,609 (76.6%)
Food & Beverage$9,498 (17.5%)
Travel$2,943 (5.4%)
Education$248.62 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $41,610 | 32 | 76.6% |
| Food and Beverage | $9,498 | 690 | 17.5% |
| Travel and Lodging | $2,943 | 15 | 5.4% |
| Education | $248.62 | 11 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $22,278 | 105 | $0 (2024) |
| Allergan, Inc. | $16,699 | 64 | $0 (2021) |
| ABBVIE INC. | $8,272 | 61 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,104 | 110 | $0 (2024) |
| Lundbeck LLC | $867.00 | 71 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $702.92 | 56 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $662.49 | 31 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $585.85 | 57 | $0 (2024) |
| Alkermes, Inc. | $559.54 | 34 | $0 (2024) |
| ITI, Inc. | $524.59 | 41 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,058 | 66 | Janssen Pharmaceuticals, Inc ($245.52) |
| 2023 | $876.25 | 46 | Otsuka America Pharmaceutical, Inc. ($218.58) |
| 2022 | $2,802 | 92 | ABBVIE INC. ($1,850) |
| 2021 | $9,101 | 106 | AbbVie Inc. ($6,365) |
| 2020 | $2,266 | 46 | Allergan, Inc. ($1,757) |
| 2019 | $4,842 | 134 | Otsuka America Pharmaceutical, Inc. ($2,121) |
| 2018 | $16,826 | 133 | Allergan Inc. ($8,391) |
| 2017 | $16,528 | 125 | Otsuka America Pharmaceutical, Inc. ($12,062) |
All Payment Transactions
748 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Neuroscience | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $14.87 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/03/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: CNS | ||||||
| 11/21/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $66.64 | General |
| Category: Neuroscience | ||||||
| 11/21/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: CNS | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: CNS | ||||||
| 10/22/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: Neuroscience | ||||||
| 10/22/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $3.42 | General |
| Category: Neuroscience | ||||||
| 10/21/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Neuroscience | ||||||
| 10/21/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $1.51 | General |
| Category: Neuroscience | ||||||
| 10/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Neuropsychiatry | ||||||
| 10/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: Neuropsychiatry | ||||||
| 10/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $2.49 | General |
| Category: Neuropsychiatry | ||||||
| 10/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: CNS | ||||||
| 09/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: CNS | ||||||
| 09/12/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Neurology | ||||||
| 09/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 43 | 90 | $21,905 | $8,731 |
| 2022 | 4 | 80 | 165 | $35,920 | $14,420 |
| 2021 | 3 | 102 | 161 | $33,450 | $16,428 |
| 2020 | 4 | 403 | 801 | $121,765 | $44,718 |
Total Patients
628
Total Services
1,217
Medicare Billing
$84,298
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 63 | $12,905 | $5,263 | 40.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 16 | $4,800 | $1,989 | 41.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 11 | 11 | $4,200 | $1,479 | 35.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 113 | $22,340 | $9,478 | 42.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 16 | $4,885 | $1,986 | 40.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 12 | 13 | $4,900 | $1,885 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 23 | $3,795 | $1,072 | 28.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 81 | $14,720 | $7,604 | 51.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 40 | 40 | $12,810 | $6,059 | 47.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 40 | $5,920 | $2,765 | 46.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 173 | 343 | $56,595 | $23,748 | 42.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 198 | 398 | $55,720 | $19,125 | 34.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 15 | 15 | $5,400 | $1,551 | 28.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 17 | 45 | $4,050 | $293.91 | 7.3% |
About Dr. Mark Mittauer, MD
Dr. Mark Mittauer, MD is a Psychiatry healthcare provider based in Groton, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255322996.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Mittauer, MD has received a total of $54,299 in payments from pharmaceutical and medical device companies, with $1,058 received in 2024. These payments were reported across 748 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($41,610).
As a Medicare-enrolled provider, Mittauer has provided services to 628 Medicare beneficiaries, totaling 1,217 services with total Medicare billing of $84,298. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Groton, CT
- Active Since 11/02/2005
- Last Updated 06/03/2015
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1255322996
Products in Payments
- VRAYLAR (Drug) $24,971
- REXULTI (Drug) $22,181
- ABILIFY MAINTENA (Drug) $711.54
- LATUDA (Drug) $702.92
- INVEGA SUSTENNA (Drug) $689.11
- CAPLYTA (Drug) $670.38
- INGREZZA (Drug) $585.85
- ARISTADA (Drug) $504.36
- AUSTEDO (Drug) $414.20
- SPRAVATO (Drug) $320.89
- Trintellix (Drug) $269.47
- VYVANSE (Drug) $252.86
- TRINTELLIX (Drug) $243.93
- BRINTELLIX (Drug) $169.71
- ABILIFY ASIMTUFII (Drug) $156.20
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $148.32
- SUNOSI (Drug) $147.84
- Fanapt (Drug) $122.24
- Austedo XR (Drug) $100.67
- MYDAYIS (Drug) $95.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Groton
Robert Grillo, M.d, M.D
Psychiatry — Payments: $276.96
Psychiatry $276.96
Dr. Kimberly Riquelme, D.o, D.O
Psychiatry — Payments: $28.66
Psychiatry $28.66
Dr. Petra Steinbuchel, Md, MD
Psychiatry — Payments: $28.47
Psychiatry $28.47
David Lobozzo, Md, MD
Psychiatry
Psychiatry
Renu Kothari, Md, MD
Psychiatry
Psychiatry
Dr. Ismail Yahyazade, Md, MD
Psychiatry
Psychiatry